Michno A, Kirkor Z et al. — Pulsed Radiofrequency Neuromodulation Contributes to Activation of Platelet-Rich Plasma in In Vitro Conditions
Neuromodulation, 2020
This in vitro study explored a novel question: can PRF activate platelet-rich plasma (PRP), and could the two therapies be usefully combined? PRP from 11 healthy volunteers was divided into four groups — resting control, thrombin-activated (positive control), PRF-treated, and thrombin + PRF combined — and assessed for markers of platelet activation and cellular safety.
Key findings:
- PRF alone induced a threefold increase in platelet factor 4 (PF4) release and a twofold increase in ATP release from PRP — both comparable to thrombin activation, which is considered maximal platelet stimulation
- Combining PRF with thrombin offered no additional benefit for PF4 release, and actually reduced ATP levels, suggesting PRF alone is sufficient to activate platelets and that over-activation is counterproductive
- PRF caused no platelet membrane damage (LDH assay) and no impact on platelet viability or metabolism (MTT assay), confirming the safety of PRF on blood cell components
- The proposed mechanism involves PRF-induced cell membrane permeabilization leading to elevated intracellular Ca²⁺, which in turn triggers granule secretion — mirroring the pathway used by physiological agonists like thrombin
Significance: This study opens a potentially important adjacent application for PRF in regenerative medicine — orthopedics, dentistry, surgery, and dermatology — beyond pain management. It suggests PRF could replace chemical platelet activators in PRP preparation, broadening the clinical and commercial relevance of PRF technology considerably.